3D Foot Scanning and Customized 3D-Printed Foot Orthotics to Reduce Pressure on the Feet of Healthy Adults
3D Surface Scanning for the Measurement of the Human Foot and Customized 3D Printed Foot Orthotics for Plantar Off-loading in Healthy Participants
The number of people with diabetes mellitus worldwide is increasing rapidly and is expected to rise to 439 million by 2030, or 7.7% of the total adult world population. The complications that can arise as a result of chronic diabetes represent a major problem in terms of clinical treatment, socio-economic consequences and costs to the health care system. One of the most serious complications is a diabetic foot, which is characterized by neuropathy, ischemia and limited joint mobility and makes the foot vulnerable to foot ulcers and possible amputation. Various interventions are being investigated to prevent foot ulcers, including custom-made foot orthotics (CFOs), also known as foot orthoses. The latter allows the health professional to achieve a number of functional effects, of which the redistribution of the plantar pressure load is the most valuable, especially in patients with so-called risk feet.
The use of integrated computer-aided design and computer-aided manufacturing systems to produce CFOs has become increasingly popular over the past decade. In practice, this digital workflow comprises three different phases. First the (3D) foot shape of the patient is recorded, then the arch support is designed using special software and finally the device is made using a subtractive or additive manufacturing process (3D printing). As a result, it can be concluded that the first two phases are decisive for determining the geometric characteristics of a CFO, while the last phase is more critical for selecting the material properties.
As for the first phase, digital approaches were developed, such as 3D optical scanning that allows the researcher to scan body parts directly, providing a robust base for determining a CFO's geometrical features. The anthropometric foot parameters examined were worth investigating, but exclusively zero-dimensional in nature, providing limited insight when assessing the 3D fit of a custom made foot orthotic. Thus, current knowledge in this area remains scarce and further efforts are needed to better understand the role of 'geometrical features' in dose-response characteristics of custom orthotics.
With regard to the production phase, additive manufacturing or 3D printing is gaining more and more attention and could potentially set a new standard for manufacturing CFOs. Limited research shows that 3D printed CFOs can be used to reduce plantar pressure in healthy and diabetic populations. However, it is important to mention that these studies have not fully exploited the possible complex design options that the additive manufacturing process can provide, as their designs are very similar to those used in less polyvalent subtractive manufacturing processes. In addition, the relief properties of previously described CFOs are not or rarely driven by patient-specific plantar pressure data.
Research design Prospective monocentric observational study with a healthy, asymptomatic population.
Objectives The main aim of this study is to evaluate the pressure distribution principle of custom orthotics in asymptomatic adults.
The study consists of two parts:
- Reliability study
- Observational study
Reliability study The methodological part of the current study consists of a reliability study with the focus on scanning the human foot. Since capturing the foot shape is the first step in the manufacturing process of custom insoles, it is important to use a reliable and objective scanning technique. This study aims to test the reliability, more specifically the intra-, inter-rater and test-retest reliability, of a portable, optical 3D scanner. In addition to the traditional zero-dimensional anthropometric measurements of the foot, mainly one-dimensional outcome measures will be studied.
Observational study In the observational part, the pressure distribution mechanism of several 3D-printed CFOs on the plantar pressure in asymptomatic patients with a so-called M2-M3 (metatarsal head of the second and third toe) pressure pattern at the level of the forefoot. There is a limited amount of literature on the effect of custom 3D-printed foot orthotics on plantar pressure distribution in healthy populations. In addition, the currently available literature appears to contain heterogeneous groups of participants with different plantar pressure distribution patterns, which complicates correct interpretation and generalization of the results, as the same orthosis designs are used for different pressure distribution patterns. During this study, several custom 3D-printed insoles, differentiated in padding density, structural architecture and geometric shape, will be applied to participants with M2-M3 forefoot patterns and then documented with a pressure distribution alg. Finally, a durability study will be conducted with the custom sole that provides the best relief from the peak pressure area of the forefoot.
Panoramica dello studio
Stato
Stato
Condizioni
Condizioni
Intervento / Trattamento
Intervento / Trattamento
Tipo di studio
Tipo di studio
Iscrizione (Effettivo)
Iscrizione
Fase
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
West-Flanders
-
Bruges, West-Flanders, Belgio, 8200
- KU Leuven Campus Bruges
-
-
Criteri di partecipazione
Criteri di ammissibilità
Criteri di ammissibilità
Età idonea allo studio
- Adulto
- Adulto più anziano
Accetta volontari sani
Descrizione
Reliability study:
The inclusion criteria:
• Healthy population, age 18-65-year-old
The exclusion criteria:
- No injury of trauma of the lower limb in the past 6 months
- No surgical procedures of the lower limbs or back in the past 6 months
- Not pregnant at the time of testing
- No (auto) immune system disorders with a possible impact on the feet (e.g., rheumatoid arthritis)
- No systemic or neurological disorder
Interventional study
The inclusion criteria:
- Healthy population, age 18-65-year-old
- Maximum weight of 90 kg
- In-shoe M2 - M3 or central pattern bilateral or left/right
The exclusion criteria:
- No injury of trauma of the lower limb in the past 6 months
- No surgical procedures of the lower limbs or back in the past 6 months
- Not pregnant at the time of testing
- No (auto) immune system disorders with a possible impact on the feet (e.g., rheumatoid arthritis)
- No systemic or neurological disorder
- Work does not require wearing safety shoes
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: N / A
- Modello interventistico: Assegnazione di gruppo singolo
- Mascheramento: Nessuno (etichetta aperta)
Numero di armi
Armi e interventi
Gruppo di partecipanti / ArmGruppo di partecipanti / Arm |
Intervento / TrattamentoIntervento / Trattamento |
|---|---|
|
Sperimentale: Within-Participant Orthotic Comparison
The study still has one experimental arm; the different orthoses are intervention conditions within that arm.
It is a single-group, within-participant repeated-measures design.
|
Foot orthotics
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Effect of custom-made foot orthotics on plantar pressure in people with a M2-3 pressure pattern.
Lasso di tempo: From enrollment to the end of the of the test at 6 weeks.
|
The main aim of this study is to evaluate the pressure distribution principle of custom orthotics in asymptomatic adults with a M2-3 pressure pattern.
|
From enrollment to the end of the of the test at 6 weeks.
|
|
Reliability of 3D scanning
Lasso di tempo: From enrollment to final scanning after 3 days.
|
To evaluate the inter-, intra-rater and test-retest reliability of 3D surface scanning for measuring and recording human foot shape in a non-weight bearing condition.
|
From enrollment to final scanning after 3 days.
|
Collaboratori e investigatori
Sponsor
Sponsor
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Inizio studio
Completamento primario (Effettivo)
Completamento primario
Completamento dello studio (Effettivo)
Completamento dello studio
Date di iscrizione allo studio
Primo inviato
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Primo Inserito
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento pubblicato
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Altri numeri di identificazione dello studio
Altri numeri di identificazione dello studio
- S67786
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .